TARGET AUDIENCE
This educational activity is intended for physiatrists, family physicians, geriatricians, neurologists, and other health care professionals who specialize in stroke care.
PROGRAM OVERVIEW
This microlearning activity uses brief, case-based scenarios to improve clinical knowledge and decision-making around post-stroke spasticity. Designed for busy health care professionals, the format delivers targeted education in short, digestible segments that promote practical application in real-world settings.
Please review this information, and proceed below
Learning Objectives
Upon completion of this course, the learners should be able to:
- Enhance awareness and knowledge of post-stroke spasticity
- Improve assessment and diagnostic accuracy of post-stroke spasticity in patients
- Understand treatment options available to patients with post-stroke spasticity
- Gain knowledge of proper referrals needed for patients with post-stroke spasticity
Faculty
Ryan Hafner, MD, FAAPMR
Physical Medicine & Rehabilitation Physician
First Physicians Group of Sarasota Memorial Health Care System
Sarasota, FL
Instructions for Participation and REQUESTING Credit
There are no fees for participating in and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pretest, completing the activity, and completing the posttest and evaluation form. A score of at least 75% on the posttest is required to successfully complete this activity. The participant may take the test until successfully passed.
Credit Fulfillment
- If you are requesting AMA credits or a certificate of participation, your certificate will be available for download
TECHNICAL REQUIREMENTS
This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox, and Safari browsers.
Additionally, this site and its activities are best viewed using the latest operating system for your device.
ACCREDITED PROVIDER

This activity is provided by the American Academy of Physical Medicine and Rehabilitation (AAPM&R).
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The American Academy of Physical Medicine and Rehabilitation and The France Foundation. The American Academy of Physical Medicine and Rehabilitation is accredited by the ACCME to provide continuing medical education for physicians.
CMECredit Designation
The American Academy of Physical Medicine and Rehabilitation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other health care professionals completing this activity will be issued a certificate stating the total time spent participating in the activity.
DISCLOSURE POLICY
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the American Academy of Physical Medicine and Rehabilitation (AAPM&R) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. AAPM&R resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, AAPM&R seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AAPM&R is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
All faculty, planners and reviewers participating in continuing medical education programs must disclose to the learner any financial interests with any commercial supporter or other relationships with manufacturer(s) or providers of any product or service related to content of their presentation. All content is peer-reviewed to ensure its quality and independence. Individuals in a position to control content and their disclosed financial relationships are listed below.
|
Name of Individual
|
Role in Activity
|
Name of Commercial Interest(s)
|
Nature of Relationship(s)
|
Mechanism(s) implemented to resolve conflict of interest
|
|
Ryan Hafner, MD, FAAPMR
|
Planning Committee Chair
|
1. AbbVie Inc, Ipsen Biopharmaceuticals, Merz Therapeutics, MicroTransponder, Inc.
|
1. Non-CE Consulting
|
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted planning committee member.
|
|
Kimberly Heckert, MD
|
Peer Reviewer
|
1. Springer Publishing
|
1. Book author royalties
|
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted planning committee member.
|
|
Richard L. Harvey, MD
|
Peer Reviewer
|
No relevant financial disclosures
|
NA
|
NA
|
|
Melissa Glasner, MS
|
Planning Committee Member
|
No relevant financial disclosures
|
NA
|
NA
|
|
Patrick Harty, PhD
|
TFF Content Reviewer
|
No relevant financial disclosures
|
NA
|
NA
|
|
Amanda Noe
|
TFF Staff
|
No relevant financial disclosures
|
NA
|
NA
|
|
Emily Peck, MS
|
TFF Staff
|
No relevant financial disclosures
|
NA
|
NA
|
FDA DISCLOSURES
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been granted.
DISCLOSURE OF UNLABELED USE:
AAPM&R requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AAPM&R does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity was supported by grants from AbbVie and Ipsen.
DISCLAIMER
The American Academy of Physical Medicine and Rehabilitation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, The American Academy of Physical Medicine and Rehabilitation, and the commercial supporter(s) assume no liability for the information herein.
COPYRIGHT INFORMATION
Copyright © 2025 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("materials") found on the site subject to the following terms, conditions, and exceptions:
- The materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered
- Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without The France Foundation's prior written permission
PRIVACY POLICY
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.
The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.
Additional information regarding The France Foundation’s privacy policy can be viewed at http://www.francefoundation.com/privacy.
CONTACT INFORMATION
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.